The Interrelationship of Menopause and Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.17140/DROJ-6-146Keywords:
Menopause T2DM, Hormone replacement therapyAbstract
Menopause is a critical time in a woman’s life which heralds the cessation of reproductive competence. There is body fat redistribution
which increases the risk of type 2 diabetes mellitus (T2DM). There is a complex interrelationship between menopause and
T2DM; several variables like the timing of the menopause, the type of menopause and the symptomatology impact this relationship.
The treatment of vasomotor symptoms with hormone replacement therapy may also impact glycemia both in women with and
without pre-existing T2DM. We tried to examine this relationship based on current scientific evidence. We also suggested strategies
to reduce the burden of T2DM in menopausal women.
References
Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al. Understanding weight gain at menopause. Cli-macteric. 2012; 15(5): 419-429. doi: 10.3109/13697137.2012.707385
Rurik I, Móczár C, Buono N, Frese T, Kolesnyk P, Mahlmeister J, et al. Early and menopausal weight gain and its relationship with the development of T2DM and hypertension. Exp Clin Endocrinol Diabetes. 2017; 125(4): 241-250. doi: 10.1055/s-0035-1569365
Kim C. Does menopause increase diabetes risk? strategies for diabetes prevention in midlife women. Womens Health. 2012; 8(2): 155-167. doi: 10.2217/whe.11.95
Peters SAE, Huxley RR, Woodward M. Diabetes as risk fac-tor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts includ-ing 858,507 individuals and 28,203 coronary events. Diabetologia. 2014; 57(8): 1542-1551. doi: 10.1007/s00125-014-3260-6
Peters SAE, Huxley RR, Woodward M. Diabetes as a risk fac-tor for stroke in women compared with men: A systematic review and meta-analysis of 64 cohorts, including 775,385 individu-als and 12,539 strokes. Lancet. 2014; 383(9933): 1973-1980. doi: 10.1016/S0140-6736(14)60040-4
Muka T, Asllanaj E, Avazverdi N, Jaspers L, Stringa N, Milic J, et al. Age at natural menopause and risk of type 2 diabetes: a pro-spective cohort study. Diabetologia. 2017; 60(10): 1951-1960. doi: 10.1007/s00125-017-4346-8
Shen L, Song L, Li H, Liu B, Zheng X, Zhang L, et al. Associa-tion between earlier age at natural menopause and risk of diabetes in middle-aged and older Chinese women: The Dongfeng–Tongji cohort study. Diabetes Metab. 2017; 43(4): 345-350. doi: 10.1016/j. diabet.2016.12.011
Wang M, Hu R-Y, Wang H, Gong W-W, Wang C-M, Xie K-X, et al. Age at natural menopause and risk of diabetes in adult women: Findings from the China Kadoorie Biobank study in the Zhejiang area. J Diabetes Investig. 2018; 9(4): 762-768. doi: 10.1111/jdi.12775
Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Dia-betes Care. 2014; 37(3): 725-733. doi: 10.2337/dc13-1986
Qiu C, Chen H, Wen J, Zhu P, Lin F, Huang B, et al. Associa-tions between age at menarche and menopause with cardiovascu-lar disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab. 2013; 98(4): 1612-1621. doi: 10.1210/jc.2012- 2919
King P, Peacock I, Donnelly R. The UK prospective diabe-tes study (UKPDS): Clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999; 48(5): 643-648. doi: 10.1046/j.1365-2125.1999.00092.x
Farahmand M, Tehrani FR, BahriKhomami M, Noroozzadeh M, Azizi F. Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based co-hort study. J Endocrinol Invest. 2015; 38(7): 761-767. doi: 10.1007/ s40618-015-0253-3
Sekhar TVDS, Medarametla S, Rahman A, Adapa SS. Early menopause in type 2 diabetes - a study from a South Indian ter-Mini Review | Volume 6 | Number 1| Lathia T et al tiary care centre. J Clin Diagn Res. 2015; 9(10): OC08-OC10. doi: 10.7860/JCDR/2015/14181.6628
Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, Me-zones-Holguín E, Barón G, Bencosme A, et al. Type II diabetes mellitus and menopause: A multinational study. Climacteric. 2013; 16(6): 663-672. doi: 10.3109/13697137.2013.798272
Khalil N, Sutton-Tyrrell K, Strotmeyer ES, Greendale GA, Vuga M, Selzer F, et al. Menopausal bone changes and incident fractures in diabetic women: A cohort study. Osteoporos Int. 2011; 22(5): 1367-1376. doi: 10.1007/s00198-010-1357-4
López-López R, Huerta R, Malacara JM. Age at menopause in women with type 2 diabetes mellitus. Menopause. 1999; 6(2): 174- 178.
Brand JS, Onland-Moret NC, Eijkemans MJC, Tjønneland A, Roswall N, Overvad K, et al. Diabetes and onset of natural meno-pause: Results from the European Prospective Investigation into Cancer and Nutrition. Hum Reprod. 2015; 30(6): 1491-1498. doi: 10.1093/humrep/dev054
Malacara JM, Huerta R, Rivera B, Esparza S, Fajardo ME. Menopause in normal and uncomplicated NIDDM women: Physical and emotional symptoms and hormone profile. Maturi-tas. 1997; 28(1): 35-45. doi: 10.1016/s0378-5122(97)00051-0
Herber-Gast G-CM, Mishra GD. Early severe vasomotor menopausal symptoms are associated with diabetes. Menopause. 2014; 21(8): 855-860. doi: 10.1097/GME.0000000000000171
Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the meno-pause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(11): 3975-4011. doi: 10.1210/jc.2015- 2236
Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, et al. Estrogen in the prevention of atherosclerosis: A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001; 135(11): 939-953. doi: 10.7326/0003-4819-135-11- 200112040-00005
Xu Y, Lin J, Wang S, Xiong J, Zhu Q. Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus. Kaohsiung J Med Sci. 2014; 30(7): 350-361. doi: 10.1016/j.kjms.2014.03.002
Salpeter SR, Walsh JME, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: Effect of hormone-replacement therapy on components of the metabolic syndrome in post-menopausal women. Diabetes Obes Metab. 2006; 8(5): 538-554. doi: 10.1111/j.1463-1326.2005.00545.x
Manson JE, Rimm EB, Colditz GA, Willett WC, Nathan DM, Arky RA, et al. A prospective study of postmenopausal estro-gen therapy and subsequent incidence of non-insulin-depen-dent diabetes mellitus. Annal Epidemiol. 1992; 2(5): 665-673. doi: 10.1016/1047-2797(92)90011-e
Espeland M, Hogan P, Fineberg SE, Howard G, Schrott H, Waclawiw M, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care. 1998; 21: 1589-1595. doi: 10.2337/diacare.21.10.1589
Friday KE, Dong C, Fontenot RU. Conjugated equine estro-gen improves glycemic control and blood lipoproteins in post-menopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2001; 86(1): 48-52.
Andersson B, Mattsson L-Å, Hahn L, MÅrin P, Lapidus L, Holm G, et al. Estrogen replacement therapy decreases hyper-androgenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent dia-betes mellitus. J Clin Endocrinol Metab. 1997; 82(2): 638-643. doi: 10.1210/jcem.82.2.3746
Brussaard HE, Leuven JAG, Frölich M, Kluft C, Krans HMJ. Short-term oestrogen replacement therapy improves insu-lin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997; 40(7): 843-849. doi: 10.1007/ s001250050758 25 Lathia T et al
Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms, and clinical implications. Endocr Rev. 2017; 38(3): 173-188. doi: 10.1210/er.2016-1146
Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: A randomized trial. Ann Intern Med. 2014; 161(4): 249-260. doi: 10.7326/M14-0353
Pan X-R, Li G-W, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The da qing IGT and diabetes study. Diabetes Care. 1997; 20(4): 537-544. doi: 10.2337/diacare.20.4.537
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläin-en H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mel-litus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18): 1343-1350. doi: 10.1056/ NEJM200105033441801
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393-403.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
